Wird geladen...
Targeted therapies for patients with advanced NSCLC harboring wild-type EGFR: what’s new and what’s enough
Historically, non-small cell lung cancer (NSCLC) is divided into squamous and nonsquamous subtypes based on histologic features. With a growing number of oncogenic drivers being identified in squamous and nonsquamous NSCLC, this malignancy has been recently divided into several distinct subtypes acc...
Gespeichert in:
| Veröffentlicht in: | Chin J Cancer |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4593374/ https://ncbi.nlm.nih.gov/pubmed/26187152 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40880-015-0036-4 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|